Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Nutrien Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Nutrien Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/14/2025 | Buy Now | — | Barclays | Benjamin Theurer62% | $59 → $61 | Maintains | Equal-Weight | Get Alert |
05/14/2025 | Buy Now | — | B of A Securities | Steve Byrne53% | $60 → $63 | Maintains | Buy | Get Alert |
05/14/2025 | Buy Now | — | Scotiabank | Ben Isaacson47% | $62 → $62 | Downgrade | Sector Outperform → Sector Perform | Get Alert |
05/13/2025 | Buy Now | — | Oppenheimer | Kristen Owen58% | $58 → $63 | Maintains | Outperform | Get Alert |
05/12/2025 | Buy Now | — | Wells Fargo | Richard Garchitorena51% | $56 → $59 | Maintains | Equal-Weight | Get Alert |
05/12/2025 | Buy Now | — | RBC Capital | Andrew Wong45% | $60 → $65 | Maintains | Outperform | Get Alert |
05/09/2025 | Buy Now | — | Goldman Sachs | Duffy Fischer58% | $53 → $59 | Maintains | Sell | Get Alert |
05/08/2025 | Buy Now | — | UBS | Eric Beaumont70% | $52 → $56 | Maintains | Neutral | Get Alert |
04/22/2025 | Buy Now | — | Oppenheimer | Kristen Owen58% | $60 → $58 | Maintains | Outperform | Get Alert |
04/16/2025 | Buy Now | — | UBS | Eric Beaumont70% | $54 → $52 | Maintains | Neutral | Get Alert |
03/13/2025 | Buy Now | — | Goldman Sachs | Duffy Fischer58% | → $53 | Initiates | → Sell | Get Alert |
03/05/2025 | Buy Now | — | Barclays | Benjamin Theurer62% | $56 → $59 | Maintains | Equal-Weight | Get Alert |
02/25/2025 | Buy Now | — | CIBC | — | $64 → $66 | Maintains | Outperformer | Get Alert |
02/24/2025 | Buy Now | — | RBC Capital | Andrew Wong45% | $60 → $60 | Reiterates | Outperform → Outperform | Get Alert |
02/24/2025 | Buy Now | — | Scotiabank | Ben Isaacson47% | $60 → $62 | Maintains | Sector Outperform | Get Alert |
02/21/2025 | Buy Now | — | Wells Fargo | Richard Garchitorena51% | $53 → $56 | Maintains | Equal-Weight | Get Alert |
02/20/2025 | Buy Now | — | Mizuho | Christopher Parkinson55% | $52 → $55 | Maintains | Neutral | Get Alert |
02/20/2025 | Buy Now | — | UBS | Eric Beaumont70% | $53 → $54 | Maintains | Neutral | Get Alert |
02/10/2025 | Buy Now | — | Scotiabank | Ben Isaacson47% | $59 → $60 | Maintains | Sector Outperform | Get Alert |
01/28/2025 | Buy Now | — | UBS | Joshua Spector54% | $51 → $53 | Maintains | Neutral | Get Alert |
01/28/2025 | Buy Now | — | Wells Fargo | Richard Garchitorena51% | $52 → $53 | Maintains | Equal-Weight | Get Alert |
01/27/2025 | Buy Now | — | Piper Sandler | Charles Neivert46% | $58 → $63 | Maintains | Overweight | Get Alert |
01/21/2025 | Buy Now | — | Barclays | Benjamin Theurer62% | $55 → $56 | Downgrade | Overweight → Equal-Weight | Get Alert |
01/13/2025 | Buy Now | — | Piper Sandler | Charles Neivert46% | $50 → $58 | Upgrade | Underweight → Overweight | Get Alert |
01/13/2025 | Buy Now | — | JP Morgan | Jeffrey Zekauskas66% | $40 → $50 | Upgrade | Underweight → Neutral | Get Alert |
12/12/2024 | Buy Now | — | Oppenheimer | Kristen Owen58% | → $60 | Initiates | → Outperform | Get Alert |
12/10/2024 | Buy Now | — | CIBC | — | $60 → $55 | Assumes | → Outperformer | Get Alert |
12/03/2024 | Buy Now | — | Raymond James | Steve Hansen63% | $58 → $60 | Upgrade | Market Perform → Outperform | Get Alert |
10/10/2024 | Buy Now | — | UBS | Joshua Spector54% | $66 → $51 | Downgrade | Buy → Neutral | Get Alert |
09/24/2024 | Buy Now | — | Wells Fargo | Richard Garchitorena51% | $62 → $50 | Downgrade | Overweight → Equal-Weight | Get Alert |
09/20/2024 | Buy Now | — | RBC Capital | Andrew Wong45% | $60 → $60 | Reiterates | Outperform → Outperform | Get Alert |
09/10/2024 | Buy Now | — | Goldman Sachs | Adam Samuelson57% | $69 → $53 | Downgrade | Buy → Neutral | Get Alert |
08/16/2024 | Buy Now | — | Barclays | Benjamin Theurer62% | $68 → $55 | Maintains | Overweight | Get Alert |
08/12/2024 | Buy Now | — | RBC Capital | Andrew Wong45% | $60 → $60 | Reiterates | Outperform → Outperform | Get Alert |
08/12/2024 | Buy Now | — | Scotiabank | Ben Isaacson47% | $66 → $59 | Maintains | Sector Outperform | Get Alert |
08/09/2024 | Buy Now | — | BMO Capital | Joel Jackson50% | $80 → $75 | Maintains | Outperform | Get Alert |
08/08/2024 | Buy Now | — | Mizuho | Christopher Parkinson55% | $55 → $52 | Maintains | Neutral | Get Alert |
07/16/2024 | Buy Now | — | Wells Fargo | Richard Garchitorena51% | $68 → $66 | Maintains | Overweight | Get Alert |
07/15/2024 | Buy Now | — | RBC Capital | Andrew Wong45% | $70 → $60 | Maintains | Outperform | Get Alert |
07/09/2024 | Buy Now | — | UBS | Joshua Spector54% | $67 → $66 | Maintains | Buy | Get Alert |
06/11/2024 | Buy Now | — | Piper Sandler | Charles Neivert46% | $56 → $55 | Maintains | Underweight | Get Alert |
05/17/2024 | Buy Now | — | Piper Sandler | Charles Neivert46% | $54 → $56 | Maintains | Underweight | Get Alert |
05/17/2024 | Buy Now | — | Mizuho | Christopher Parkinson55% | $54 → $56 | Maintains | Underweight | Get Alert |
05/10/2024 | Buy Now | — | Wells Fargo | Richard Garchitorena51% | $67 → $68 | Maintains | Overweight | Get Alert |
05/09/2024 | Buy Now | — | Mizuho | Christopher Parkinson55% | $54 → $59 | Maintains | Neutral | Get Alert |
04/29/2024 | Buy Now | — | Berenberg | Aron Ceccarelli53% | $60 → $66 | Upgrade | Hold → Buy | Get Alert |
03/26/2024 | Buy Now | — | Jefferies | Laurence Alexander75% | → $62 | Initiates | → Buy | Get Alert |
03/01/2024 | Buy Now | — | Wolfe Research | Chris Parkinson79% | — | Initiates | → Outperform | Get Alert |
02/29/2024 | Buy Now | — | Piper Sandler | Charles Neivert46% | $68 → $54 | Downgrade | Neutral → Underweight | Get Alert |
02/26/2024 | Buy Now | — | Wells Fargo | Richard Garchitorena51% | $77 → $69 | Maintains | Overweight | Get Alert |
02/23/2024 | Buy Now | — | RBC Capital | Andrew Wong45% | $75 → $70 | Maintains | Outperform | Get Alert |
02/23/2024 | Buy Now | — | JP Morgan | Jeffrey Zekauskas66% | $58 → $48 | Downgrade | Neutral → Underweight | Get Alert |
02/01/2024 | Buy Now | — | Goldman Sachs | Adam Samuelson57% | $88 → $78 | Maintains | Buy | Get Alert |
01/19/2024 | Buy Now | — | Stifel | Vincent Anderson74% | $72 → $75 | Maintains | Buy | Get Alert |
01/12/2024 | Buy Now | — | Raymond James | Steve Hansen63% | $80 → $65 | Downgrade | Outperform → Market Perform | Get Alert |
11/14/2023 | Buy Now | — | Barclays | Benjamin Theurer62% | $64 → $68 | Upgrade | Underweight → Overweight | Get Alert |
11/06/2023 | Buy Now | — | JP Morgan | Jeffrey Zekauskas66% | $70 → $58 | Downgrade | Overweight → Neutral | Get Alert |
11/03/2023 | Buy Now | — | RBC Capital | Andrew Wong45% | $85 → $80 | Maintains | Outperform | Get Alert |
08/14/2023 | Buy Now | — | Barclays | Benjamin Theurer62% | $70 → $68 | Downgrade | Overweight → Underweight | Get Alert |
08/08/2023 | Buy Now | — | RBC Capital | Andrew Quail32% | → $85 | Reiterates | Outperform → Outperform | Get Alert |
08/07/2023 | Buy Now | — | Piper Sandler | Charles Neivert46% | $70 → $73 | Maintains | Neutral | Get Alert |
08/04/2023 | Buy Now | — | Mizuho | Christopher Parkinson55% | $74 → $73 | Maintains | Neutral | Get Alert |
07/31/2023 | Buy Now | — | TD Cowen | Michael Tupholme39% | $72 → $83 | Upgrade | Hold → Buy | Get Alert |
07/26/2023 | Buy Now | — | HSBC | Santhosh Seshadri71% | $81 → $72 | Maintains | Hold | Get Alert |
07/25/2023 | Buy Now | — | Morgan Stanley | Vincent Sinisi72% | $70 → $70 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/24/2023 | Buy Now | — | Wells Fargo | Richard Garchitorena51% | $62 → $82 | Upgrade | Equal-Weight → Overweight | Get Alert |
07/19/2023 | Buy Now | — | Morgan Stanley | Vincent Sinisi72% | $70 → $70 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/18/2023 | Buy Now | — | Goldman Sachs | Adam Samuelson57% | $136 → $121 | Maintains | Buy | Get Alert |
06/08/2023 | Buy Now | — | B of A Securities | Steve Byrne53% | $94 → $85 | Maintains | Buy | Get Alert |
06/01/2023 | Buy Now | — | Barclays | Benjamin Theurer62% | $80 → $70 | Maintains | Overweight | Get Alert |
05/30/2023 | Buy Now | — | Morgan Stanley | Vincent Sinisi72% | $80 → $70 | Maintains | Equal-Weight | Get Alert |
05/19/2023 | Buy Now | — | JP Morgan | Jeffrey Zekauskas66% | $92 → $78 | Maintains | Overweight | Get Alert |
05/18/2023 | Buy Now | — | Piper Sandler | Charles Neivert46% | $82 → $70 | Maintains | Neutral | Get Alert |
05/17/2023 | Buy Now | — | Berenberg | Aron Ceccarelli53% | $92 → $49 | Downgrade | Buy → Hold | Get Alert |
05/16/2023 | Buy Now | — | BMO Capital | Joel Jackson50% | $110 → $90 | Maintains | Outperform | Get Alert |
05/15/2023 | Buy Now | — | Wells Fargo | Richard Garchitorena51% | $82 → $62 | Maintains | Equal-Weight | Get Alert |
05/12/2023 | Buy Now | — | RBC Capital | Andrew Quail32% | $100 → $95 | Maintains | Outperform | Get Alert |
05/12/2023 | Buy Now | — | Raymond James | Steve Hansen63% | → $85 | Upgrade | Market Perform → Outperform | Get Alert |
05/12/2023 | Buy Now | — | Mizuho | Christopher Parkinson55% | $79 → $75 | Maintains | Neutral | Get Alert |
05/12/2023 | Buy Now | — | Barclays | Benjamin Theurer62% | $93 → $80 | Maintains | Overweight | Get Alert |
05/11/2023 | Buy Now | — | Credit Suisse | Edlain Rodriguez67% | $70 → $60 | Reiterates | Underperform → Underperform | Get Alert |
04/19/2023 | Buy Now | — | Goldman Sachs | Adam Samuelson57% | $119 → $106 | Maintains | Buy | Get Alert |
04/14/2023 | Buy Now | — | Barclays | Benjamin Theurer62% | $95 → $93 | Maintains | Overweight | Get Alert |
04/12/2023 | Buy Now | — | Morgan Stanley | Vincent Sinisi72% | $91 → $80 | Maintains | Equal-Weight | Get Alert |
04/10/2023 | Buy Now | — | Scotiabank | Ben Isaacson47% | $95 → $90 | Upgrade | Sector Perform → Sector Outperform | Get Alert |
04/06/2023 | Buy Now | — | UBS | Joshua Spector54% | $100 → $99 | Maintains | Buy | Get Alert |
03/28/2023 | Buy Now | — | Erste Group | Hans Engel64% | — | Downgrade | Buy → Hold | Get Alert |
02/23/2023 | Buy Now | — | JP Morgan | Jeffrey Zekauskas66% | → $92 | Maintains | Overweight | Get Alert |
02/21/2023 | Buy Now | — | RBC Capital | Andrew Quail32% | $115 → $110 | Maintains | Outperform | Get Alert |
02/21/2023 | Buy Now | — | HSBC | Santhosh Seshadri71% | $83 → $81 | Maintains | Hold | Get Alert |
02/17/2023 | Buy Now | — | Wells Fargo | Richard Garchitorena51% | $80 → $82 | Maintains | Equal-Weight | Get Alert |
02/16/2023 | Buy Now | — | UBS | Joshua Spector54% | $103 → $100 | Maintains | Buy | Get Alert |
02/16/2023 | Buy Now | — | Credit Suisse | Edlain Rodriguez67% | $65 → $70 | Maintains | Underperform | Get Alert |
02/08/2023 | Buy Now | — | TD Securities | Michael Tupholme39% | — | Downgrade | Buy → Hold | Get Alert |
02/03/2023 | Buy Now | — | Raymond James | Steve Hansen63% | — | Downgrade | Outperform → Market Perform | Get Alert |
01/30/2023 | Buy Now | — | RBC Capital | Andrew Wong45% | $120 → $115 | Maintains | Outperform | Get Alert |
01/20/2023 | Buy Now | — | Citigroup | PJ Juvekar68% | $87 → $86 | Maintains | Buy | Get Alert |
01/19/2023 | Buy Now | — | Wells Fargo | Richard Garchitorena51% | → $80 | Initiates | → Equal-Weight | Get Alert |
01/13/2023 | Buy Now | — | JP Morgan | Jeffrey Zekauskas66% | $98 → $95 | Maintains | Overweight | Get Alert |
01/12/2023 | Buy Now | — | Mizuho | Christopher Parkinson55% | $93 → $91 | Maintains | Neutral | Get Alert |
The latest price target for Nutrien (NYSE:NTR) was reported by Barclays on May 14, 2025. The analyst firm set a price target for $61.00 expecting NTR to rise to within 12 months (a possible 7.02% upside). 41 analyst firms have reported ratings in the last year.
The latest analyst rating for Nutrien (NYSE:NTR) was provided by Barclays, and Nutrien maintained their equal-weight rating.
The last upgrade for Nutrien Ltd happened on January 13, 2025 when Piper Sandler raised their price target to $58. Piper Sandler previously had an underweight for Nutrien Ltd.
The last downgrade for Nutrien Ltd happened on May 14, 2025 when Scotiabank changed their price target from $62 to $62 for Nutrien Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nutrien, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nutrien was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.
While ratings are subjective and will change, the latest Nutrien (NTR) rating was a maintained with a price target of $59.00 to $61.00. The current price Nutrien (NTR) is trading at is $57.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.